Literature DB >> 32839270

Circular RNAs in cell differentiation and development.

Gaia Di Timoteo1, Francesca Rossi1, Irene Bozzoni2,3.   

Abstract

In recent years, circular RNAs (circRNAs) - a novel class of RNA molecules characterized by their covalently closed circular structure - have emerged as a complex family of eukaryotic transcripts with important biological features. Besides their peculiar structure, which makes them particularly stable molecules, they have attracted much interest because their expression is strongly tissue and cell specific. Moreover, many circRNAs are conserved across eukaryotes, localized in particular subcellular compartments, and can play disparate molecular functions. The discovery of circRNAs has therefore added not only another layer of gene expression regulation but also an additional degree of complexity to our understanding of the structure, function and evolution of eukaryotic genomes. In this Review, we summarize current knowledge of circRNAs and discuss the possible functions of circRNAs in cell differentiation and development.
© 2020. Published by The Company of Biologists Ltd.

Keywords:  Developmental biology; Differentiation; Noncoding RNAs; Stem cells; circRNAs

Mesh:

Substances:

Year:  2020        PMID: 32839270     DOI: 10.1242/dev.182725

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  15 in total

1.  Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.

Authors:  Rong Niu; Dong Li; Jian Chen; Wentao Zhao
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

Review 2.  Specific expression and functions of circular RNAs.

Authors:  Sema Misir; Nan Wu; Burton B Yang
Journal:  Cell Death Differ       Date:  2022-02-15       Impact factor: 12.067

3.  Circ_0001367 inhibits glioma proliferation, migration and invasion by sponging miR-431 and thus regulating NRXN3.

Authors:  Liang Liu; Peng Zhang; Xuchen Dong; Haoran Li; Suwen Li; Shan Cheng; Jiaqi Yuan; Xuejun Yang; Zhiyuan Qian; Jun Dong
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

Review 4.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

Review 5.  Retrotransposons as Drivers of Mammalian Brain Evolution.

Authors:  Roberto Ferrari; Nicole Grandi; Enzo Tramontano; Giorgio Dieci
Journal:  Life (Basel)       Date:  2021-04-22

6.  Circular RNA CircCOL5A1 Sponges the MiR-7-5p/Epac1 Axis to Promote the Progression of Keloids Through Regulating PI3K/Akt Signaling Pathway.

Authors:  Wenchang Lv; Shengxuan Liu; Qi Zhang; Weijie Hu; Yiping Wu; Yuping Ren
Journal:  Front Cell Dev Biol       Date:  2021-01-21

7.  Circ0083429 Regulates Osteoarthritis Progression via the Mir-346/SMAD3 Axis.

Authors:  Teng Yao; Yute Yang; Ziang Xie; Yining Xu; Yizhen Huang; Jun Gao; Shuying Shen; Huali Ye; Yasaman Iranmanesh; Shunwu Fan; Jianjun Ma
Journal:  Front Cell Dev Biol       Date:  2021-01-15

8.  Identification of Potential circRNA-microRNA-mRNA Regulatory Network in Skeletal Muscle.

Authors:  Arundhati Das; Sharmishtha Shyamal; Tanvi Sinha; Smruti Sambhav Mishra; Amaresh C Panda
Journal:  Front Mol Biosci       Date:  2021-11-29

9.  CircVAMP3: A circRNA with a Role in Alveolar Rhabdomyosarcoma Cell Cycle Progression.

Authors:  Francesca Rossi; Alvaro Centrón-Broco; Dario Dattilo; Gaia Di Timoteo; Marco Guarnacci; Alessio Colantoni; Manuel Beltran Nebot; Irene Bozzoni
Journal:  Genes (Basel)       Date:  2021-06-28       Impact factor: 4.096

10.  Hsa_circ_0002062 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells by Regulating the Hsa-miR-942-5p/CDK6 Signaling Pathway.

Authors:  Yali Wang; Xiaoming Tan; Yunjiang Wu; Sipei Cao; Yueyan Lou; Liyan Zhang; Feng Hu
Journal:  Front Genet       Date:  2021-07-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.